STERIS plc
For the period ended Mar 31, 2024. Filed May 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed May 29, 2024
STE$256.94+1.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| March 31, | 2024 | 2023 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $207,020 | $208,357 |
| Accounts receivable (net of allowances of $22,984 and $19,284, respectively) | 1,008,315 | 864,988 |
| Inventories, net | 674,535 | 604,410 |
| Prepaid expenses and other current assets | 174,349 | 176,107 |
| Current assets held for sale | 804,904 | 157,580 |
| Total current assets | 2,869,123 | 2,011,442 |
| Property, plant, and equipment, net | 1,765,180 | 1,632,775 |
| Lease right-of-use assets, net | 173,201 | 166,553 |
| Goodwill | 4,070,712 | 3,879,219 |
| Intangibles, net | 2,119,282 | 2,076,699 |
| Other assets | 66,199 | 77,892 |
| Non-current assets held for sale | — | 977,259 |
| Total assets | $11,063,697 | $10,821,839 |
| Liabilities and equity | ||
| Current liabilities: | ||
| Accounts payable | $251,723 | $264,165 |
| Accrued income taxes | 13,640 | 40,477 |
| Accrued payroll and other related liabilities | 164,831 | 118,463 |
| Short-term lease obligations | 31,239 | 30,065 |
| Short term indebtedness | 85,938 | 60,000 |
| Accrued expenses and other | 319,744 | 298,032 |
| Current liabilities held for sale | 64,012 | 50,642 |
| Total current liabilities | 931,127 | 861,844 |
| Long-term indebtedness | 3,120,162 | 3,018,655 |
| Deferred income taxes, net | 479,688 | 617,538 |
| Long-term lease obligations | 145,828 | 139,557 |
| Other liabilities | 71,546 | 76,137 |
| Non-current liabilities held for sale | — | 20,936 |
| Total liabilities | $4,748,351 | $4,734,667 |
| Commitments and contingencies (see Note 12) | ||
| Ordinary shares, with $0.001 par value; 500,000 shares authorized; 98,883 and 98,629 ordinary shares issued and outstanding, respectively | 4,543,176 | 4,486,375 |
| Retained earnings | 2,087,645 | 1,911,533 |
| Accumulated other comprehensive loss | (328,657) | (320,710) |
| Total shareholders’ equity | 6,302,164 | 6,077,198 |
| Noncontrolling interests | 13,182 | 9,974 |
| Total equity | 6,315,346 | 6,087,172 |
| Total liabilities and equity | $11,063,697 | $10,821,839 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.